Pure Himalayan Shilajit - Get 50% Off X
Esiflo 250 Transcaps is a commercial drug that is prescribed in the form of Transcaps. Other than this, Esiflo 250 Transcaps has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Esiflo 250 Transcaps depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Common side effects of Esiflo 250 Transcaps include Shortness of Breath, Throat Irritation, Nosebleed. Besides the aforementioned side effects, there are other adverse effects of Esiflo 250 Transcaps as well, which are listed below. Normally, these side effects of Esiflo 250 Transcaps are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Esiflo 250 Transcaps is Moderate for pregnant women and Mild for women who are breastfeeding. Further, the section on Esiflo 250 Transcaps related warnings talks about Esiflo 250 Transcaps's effects on the liver, heart and kidney.
Other contraindications of Esiflo 250 Transcaps have been discussed in the sections ahead.
Additionally, Esiflo 250 Transcaps may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Esiflo 250 Transcaps, it is important to know that it is safe while driving, and is habit-forming.
Esiflo 250 Transcaps is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Esiflo 250 Transcaps is used -
Moderate
Mild
Common
Unknown
Is the use of Esiflo 250 Transcaps safe for pregnant women?
Esiflo can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Esiflo right away. Take your doctor's advice before taking it again.
Is the use of Esiflo 250 Transcaps safe during breastfeeding?
Breastfeeding women can take Esiflo as it bears very minor side effects for them.
What is the effect of Esiflo 250 Transcaps on the Kidneys?
Using Esiflo does not have any harmful effects on kidneys.
What is the effect of Esiflo 250 Transcaps on the Liver?
You may experience side effects on your liver after taking Esiflo. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Esiflo 250 Transcaps on the Heart?
Esiflo can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Esiflo 250 Transcaps should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Esiflo 250 Transcaps unless your doctor advises you to do so -
Is this Esiflo 250 Transcaps habit forming or addictive?
Esiflo 250 Transcaps does not cause addiction.
Interaction between Food and Esiflo 250 Transcaps
There is no information on the effects of taking Esiflo 250 Transcaps with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Esiflo 250 Transcaps
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Esiflo 250 Transcaps.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359